- No public price. Veradigm publishes no pricing.
- Not disclosed
- Not disclosed
- —
- —
Population health
Veradigm
by Veradigm
Healthcare technology company: ePrescribing, a payer network and real-world data from EHR records (formerly Allscripts).
On this page
11/100Tracked
- Regulatory & Compliance0/22
No FDA clearance listed
- Clinical Integration0/31.8
No EHR integrations listed
- Evidence Strength0/20
No peer-reviewed coverage
- Vendor & Market9/24
Early-stage company
- Sentiment & Transparency3/15
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/18
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/10
None of the top-3 EHRs covered
- Bidirectional write-back0/4
No bidirectional write-back documented
- Peer-reviewed papers0/14
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/6
No RCT, meta-analysis, or systematic review
- Funding & adoption signal9/18
Early-stage company
- Years in market0/6
Founded year not recorded
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/6
Pricing on request, no public amounts
Healthcare technology company: ePrescribing, a payer network and real-world data from EHR records (formerly Allscripts).
No public price. Veradigm publishes no pricing.
Bottom line
Veradigm is a Chicago health IT company, formerly Allscripts, that sells ePrescribing, a payer network and de-identified EHR data to life-science customers. Practices on Practice Fusion and EHR vendors that embed its prescribing engine are its direct users. Nasdaq delisted the company in February 2024 after years of late financials, and shareholder litigation continues.
What is Veradigm and who sells it?
Veradigm Inc. renamed itself from Allscripts Healthcare Solutions on 3 January 2023. Practice Fusion, which Allscripts acquired in 2018, is now a Veradigm product, and Tali AI's site lists Practice Fusion and Veradigm among its US EHR integrations.
Veradigm missed its 2022 annual report and its 2023 quarterly filings, and Nasdaq delisted it effective 29 February 2024. It now trades over the counter as MDRX. The board ended a strategic-alternatives review, which had been looking at a sale, by January 2025. The SEC closed its investigation on 20 February 2026 without enforcement action, according to Healthcare Dive. The company filed a combined 2023 and 2024 annual report on 26 May 2026 but had not filed 2025 reports by mid-October 2026, and its second-quarter 2026 filing was late.
On the financial side, StockTitan's summary of an 8-K reports estimated 2025 revenue of $584M to $589M, a new $100M credit facility and a new CEO. Securities and derivative lawsuits continue.
What does it sell?
The website describes a healthcare technology company with three segments. Provider covers ePrescribing, including controlled substances, plus ePrescribe Enterprise for EHR vendors. Payer connects health plans to the Veradigm Network of providers. Life Sciences sells data and insights from the point of care, including NLP-enriched real-world data from EHRs.
ePrescribing is described as certified without naming the certifying body, and the homepage makes no security attestation. ONC and privacy pages are linked in the footer. Prices are not listed on the site.
What research uses Veradigm data?
Five papers carry Veradigm data, among them hospitalization after outpatient RSV diagnosis in adults (JAMA Network Open, 2024). They are database studies. None evaluates a Veradigm AI product.
The verdict
For a practice already on Practice Fusion or an EHR with Veradigm prescribing, the corporate record is the item to weigh: the 2025 annual report remains outstanding and the second-quarter 2026 filing was late. A practice choosing a new EHR has that to weigh against any alternative. The data business sells to life-science customers and gives a clinic no reason to choose or avoid the company.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | — | — | No public price. Veradigm publishes no pricing. |
Source: vendor pricing page. Last checked October 15, 2026.
Who builds it
It was previously known as Allscripts, an acquisition or rebrand that healthcare-AI buyers should track when reviewing prior independent coverage.
Other population health
See the full population health ranking
Innovaccer Healthcare Intelligence
by Innovaccer
The Agentic Cloud for Healthcare: a data platform with AI agents for care coordination, revenue cycle and population health.
No public price. The homepage shows none.
Optum Population Health
by Optum
Optum's value-based care software and services for payers and providers, including Value Connect, the ACO Solution and Symmetry.
No public price. Contracts are enterprise-negotiated.
Healthy
by Healthy (formerly ClosedLoop)
Healthcare AI platform that automates predictive model development for payers, providers and ACOs. Also offers a consumer health app.
No public price. A 2023 release described the ACO-Predict risk-stratification product as free. Current availability was not checked.
Health Catalyst
by Health Catalyst
Data and analytics platform for health systems (Ignite), with population health, value-based care and regulatory solutions.
No public price. The homepage shows none.